This Week in Science

The editor-in-chief of Science decries Pfizer's subpoena served on the New England Journal of Medicine. Pfizer is being sued by plaintiffs who say that Celebrex and Bextra cause cardiovascular and other injuries, and some of them may point to NEJM papers to back up their claims. Pfizer, then, wants to look through the confidential peer-reviews of those, saying the public has no interest in protecting the editorial process of a journal.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.